Understanding the Process of Documenting Informed Consent

Slides:



Advertisements
Similar presentations
1 US Investigator Meeting DIAS-4, Chicago, July 2011 Informed Consent.
Advertisements

Tips to a Successful Monitoring Visit
Research Informed Consent
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
 IRB Webinar 11/13/2014.  To recognize how to conduct an adequate informed consent process in adults and children  To learn how to manage the process.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
John Naim, PhD Director Clinical Trials Research Unit
Neurological Emergencies Treatment Trials Network RAMPART This award is funded with support of NINDS, BARDA and the NIH CounterACT program.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Jennifer McCormick MA, CRC Karla Lichter RN CCRC.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
“So You Think You Know GCP …” Session S794 Jill Matzat, RN, BSN, CCRA, CCRT President, Medical Research Management & CRA Solutions, Inc. Paul Below, CCRA,
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Ensuring Human Subject Protection A Guide for Those who Obtain Research Informed Consent Documents 10/15/20151.
HUMAN SUBJECTS PROTECTION PROGRAM Office Location: 1350 N. Vine Ave. (one block west of Cherry Ave. & three blocks north of Speedway) PO Box Phone:
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
VHA Handbook What’s new. General Requirements for Informed Consent A Legally Authorized Representative may not always qualify as a ‘personal representative’
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Investigational Devices and Humanitarian Use Devices June 2007.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
INVESTIGATOR RESPONSIBILITIES C. Karen Jeans, MSN COACH Project Analyst.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
HIPAA Training Workshop #3 Individual Rights Kaye L. Rankin Rankin Healthcare Consultants, Inc.
Data Management: Source Documents, Case Report Forms and Electronic Data Thomas Salerno, RN BSN MA Senior Team Lead Cardiology Research Jefferson Clinical.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Good Clinical Practice (GCP) and Monitoring Practices
Instructions for New IRB Continuing Review (Progress) Report
The Role and Responsibilities of the Clinical Research Coordinator
Incident Reporting And Investigation Program
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Responsibilities of Sponsor, Investigator and Monitor
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
MAINTAINING THE INVESTIGATOR’S SITE FILE
The HIPAA Privacy Rule: Implications for Medical Research
IRB reporting updates.
Investigator of Record – Definition
Reportable Events & Other IRB Updates February 2017
Alyssa Speier, MS, CIP November 13, 2013
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Regulatory Binder: Maintaining Essential Study Documentation
Basics of Building and Understanding Data Collection Forms
Basic Informed Consent Training: Part II
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Incident Reporting And Investigation Program
Investigator of Record – Definition
Investigator of Record – Definition
Elements of a Successful Informed Consent
MAINTAINING THE INVESTIGATOR’S STUDY FILE
TRTO (Translational Research Trials Office)
Monitoring, Auditing and Compliance
Quality Assurance in Clinical Trials
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Protocol Approval Criteria
Good clinical practice
Presentation transcript:

Understanding the Process of Documenting Informed Consent Anne Roussell, RN Office of Clinical Research

QA Study Audits The purpose: provide principal investigators (PI) and study teams early detection regarding study conduct issues; provide education to investigators and study teams about best practices related to institutional, regulatory and Good Clinical Practice standards; and identify broad areas of need within UMMS related to education, training and resource development for the research community.

QA Study Audits Findings 2013-2014 2014-2015 2015-2016 2016-2017 2017-2018 # studies reviewed 79 80 75 66 15* Total # subjects 5423 2640 3108 4523 303 IC/HIPAA 3320 1047 635 318 44 Protocol Adherence 74 60 24 2 IRB Documents 56 15 34 3 7 Regulatory Documents 17 28 10 * Partial year audits

Informed Consent/HIPAA Findings 2013-2014 2014-2015 2015-2016 2016-2017 2017-2018 # IC Findings 3320 1047 635 318 44 Missing IRB stamp 1698 598 127 188 IC dated for subject 384 144 113 11 9 Missing HIPAA 359 86 141 7 Non-approved consenter 24 26 20 2 Signature blocks not completed (if applicable) 29 17

Informed Consent/HIPAA Findings (con’t) 2013-2014 2014-2015 2015-2016 2016-2017 2017-2018 # IC Findings 3320 1047 635 318 44 Dates don’t match 54 23 3 2 4 Missing dates/signatures 205 26 65 18 Incorrect version 207 19 15 60 Assent not obtained 43 White-out used 45 1 Missing dates 216 12 Missing Consents 13 6 Missing pages 62 107 25

Common Deficiencies Can you spot the errors?

Approved UMass Medical School IRB: Do not sign this form after this date: 5/13/2014

Reasons For Missing eIRB Stamp Study staff didn’t know it was required Printed consent and HIPAA on wrong side of the eIRB protocol page Printer or copy machine is cutting off the stamp Staff turnover (back to reason 1)

IRB Guidance HRP-802 3.1.     Obtain the IRB-approved consent document, short form consent document, or script, as applicable. 3.1.1.      Verify that you are using the most current IRB-approved information. Requirement also noted on the IRB approval letter.

Approved UMass Medical School IRB: Do not sign this form after this date: 10/30/2015

Approved UMass Medical School IRB: Do not sign this form after this date: 10/29/2015

Approved UMass Medical School IRB: Do not sign this form after this date: 1/8/2015

IRB Guidance HRP-803 3.1.3. Have the following individuals personally sign and date the consent document: 3.1.3.1. Person giving consent (FDA 21 CFR 50.27) 3.1.3.2. Person obtaining consent

Approved UMass Medical School IRB: Do not sign this form after this date: 5/5/2015

Investigator Obligations HRP-800 2.10. Submit proposed modifications to the IRB prior to their implementation. 2.10.1. Do not make modifications to the research without prior IRB review and approval unless necessary to eliminate apparent immediate hazards to subjects.

Documenting consent process “The case history for each individual shall document that informed consent was obtained prior to participation in the study”. (FDA 21 CFR 312.62(b)) Case history can be a progress note or other source document What should be included: Consent provided to subject and subject had a chance to read Study team member explains study to subject Subject had an opportunity to ask questions Subject willing to participate and signed and dated the consent Investigator or designee signed and dated the consent Subject was given a copy of the signed and dated consent form ICH GCP E6 is silent on documenting consent process

Informed Consent Frequently Asked Questions

Informed Consent FAQs How do you correct dating errors? Missing dates or incorrect dates FDA is silent. Sites can develop their own procedures Never backdate a consent form! Best practice recommendation: At the next subject visit, the subject should write a note and attach to the consent form stating that the form was originally signed on such and such a date before study procedures were initiated.

Informed Consent FAQs Can you obtain consent over the phone, by fax or by electronic informed consent? Methods must be approved by the IRB first. If the ISP states consent will be in writing, then no, phone consent is not allowed Subject can sign and fax back the consent FDA accepts electronic signatures to document electronic informed consent. (FDA Guidance for Industry: Use of Electronic Informed Consent) According to the FDA, the consent form may be sent to the subject or the subject’s legally authorized representative by facsimile or e-mail, and the consent interview may then be conducted by telephone when the subject or subject’s legally authorized representative can read the consent form during the discussion. After the consent discussion, the subject or the subject’s legally authorized representative can sign and date the consent form and return the document to the clinical investigator by facsimile, scanning the consent form and returning it through a secure e-mail account, or by posting it to a secure internet address.

Informed Consent FAQs Who can obtain consent? ICH GCP 4.8.5 states the person conducting the informed consent discussion can be a “person designated by the investigator”. FDA does not specify Identify who will be obtaining consent in the eIRB system. (HRP-800:Investigator Obligations)

Informed Consent FAQs What is an impartial witness? Someone not associated with the trial When should a witness be used? ICH GCP 4.8.9: If a subject is unable to read or if a legally acceptable representative is unable to read, an impartial witness should be present during the entire informed consent discussion and sign and date the consent form.

Informed Consent FAQs How long do you retain the informed consent and HIPAA documents? Retain research records (including signed consent documents) for the greater of: Three years after completion of the research Maintain signed and dated consent documents for at least three years after completion of the research. Maintain signed and dated HIPAA authorizations and consent documents that include HIPAA authorizations for at least six years after completion of the research. (HRP-800: Investigator Obligations)

(HRP-800: Investigator Obligations) Informed Consent FAQs Do copies of the informed consent need to be in the EMR? If the research includes procedures which are or can affect clinical care, a copy of the signed consent form must be placed in the UMass Memorial medical record (HRP-800: Investigator Obligations) Scanned copies should be sent to: epicmedicalrecordnumberissues@umassmemorial.org

UMass IRB Policies and Procedures http://www.umassmed.edu/ccts/irb/investigator-guidance/ HRP-800: Investigator Obligations HRP-802: Informed Consent HRP-803: Documentation of Informed Consent

Questions?